...BRCA2 mutations and time to breast or ovarian cancer diagnosis were found. An attempt to handle a potential selection bi...
...BRCA2, associated with Hereditary Breast & Ovarian Cancer syndrome, have up to an 85% lifetime risk of breast cancer and...
...BRCA2 carriers were identified from the database. Median Kaplan-Meier estimate of survival was 46.0 years (44.9-48.1) fo...
...BRCA2 mutated families. We tested the COS performance in 436 Italian breast/ovarian cancer families including 79 with BR...
...BRCA2-Asn372His) and the clinical outcome of patients with primary small cell carcinoma of esophagus (SCCE), and it show...
...BRCA2/FANCD1 mutations; five of these featured more than one malignancy and the median age at the time of cancer diagnos...
...BRCA2 in order to investigate the impact of variants on splicing. BRCA2 exons 19-27 (MGBR2_ex19-27) were cloned in the n...
...BRCA2 mutation. The mean age of patients at diagnosis of EOC was 49.5 years (range, 28-89 years). Of the 135 patients, 1...
...BRCA2 were analyzed by Sanger sequencing.,12 patients had deleterious mutations in the BRCA1 or BRCA2 genes (18%), inclu...
...BRCA2 gene mutation. The intervention involved trained peer volunteers contacting women multiple times over a 4-month pe...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2025.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
